Evidence map›Paper›PMID 39023197›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

A Linkable, Polycarbonate Gut Microbiome-Distal Tumor Chip Platform for Interrogating Cancer Promoting Mechanisms.

Danielle S K Brasino, Sean D Speese, Kevin Schilling, Carolyn E Schutt, Michelle C Barton

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Design strategy primer for organ-on-chips.Biomaterials translational · 2025
    Article
  9. Host-microbe-cancer interactions on-a-chip.Frontiers in bioengineering and biotechnology · 2025
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Danielle S K BrasinoCancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97201, USA.ORCID 0000-0002-8274-0955
Sean D SpeeseCancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97201, USA.ORCID 0000-0002-3965-9828
Kevin SchillingCancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97201, USA.ORCID 0000-0001-7806-4117
Carolyn E SchuttCancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97201, USA.ORCID 0000-0002-6614-052X
Michelle C BartonCancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97201, USA.ORCID 0000-0002-4042-1374

Funding

Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
Genetically Manipulating Protein Expression to Probe 3D Cell Behavior using Ultrasound-Responsive BiomaterialsR35GM151057 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Carolyn Schutt Ibsen · 2023 to 2026
$1.5M
Cancer Early Detection Advanced Research Center at Oregon Health & Science University's Knight Cancer Institute and the Collins Medical Trust in Portland, OregonCancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University Exploratory6781119Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University Full 2021-1391Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University Full 2023-1773Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University Full6950120Collins Medical TrustNational Institute of General Medical Sciences (NIGMS)NCI NIH HHS P30 CA069533NIGMS NIH HHS R35 GM151057NIH HHS R35GM151057
6 · The paper itself

Abstract

Gut microbiome composition is tied to diseases ranging from arthritis to cancer to depression. However, mechanisms of action are poorly understood, limiting development of relevant therapeutics. Organ-on-chip platforms, which model minimal functional units of tissues and can tightly control communication between them, are ideal platforms to study these relationships. Many gut microbiome models are published to date but devices are typically fabricated using oxygen permeable polydimethylsiloxane, requiring interventions to support anaerobic bacteria. To address this challenge, a platform is developed where the chips are fabricated entirely from gas-impermeable polycarbonate without tapes or gaskets. These chips replicate polarized villus-like structures of the native tissue. Further, they enable co-cultures of commensal anaerobic bacteria Blautia coccoides on the surface of gut epithelia for two days within a standard incubator. Another complication of commonly used materials in organ-on-chip devices is high ad-/absorption, limiting applications in high-resolution microscopy and biomolecule interaction studies. For future communication studies between gut microbiota and distal tumors, an additional polycarbonate chip design is developed to support hydrogel-embedded tissue culture. These chips enable high-resolution microscopy with all relevant processing done on-chip. Designed for facile linking, this platform will make a variety of mechanistic studies possible.

Indexed as

Gastrointestinal MicrobiomePolycarboxylate CementAnimalsEquipment DesignHumansLab-On-A-Chip DevicesMiceNeoplasmspolycarbonatePolycarboxylate Cementcancergut microbiomesmicrophysiological systemsorgan‐on‐chips

Identifiers

PMID39023197
PMCPMC11425222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.